See also this year's filing and all EDGAR filings for this company.
PDF Report 0001395937_2023_Syndax_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001395937, Syndax Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 489,786,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,000 |
| 3 | remainder_Assets | 7,430,000 |
| 4 | LiabilitiesCurrent | 29,065,000 |
| 5 | LiabilitiesNoncurrent | 722,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 33,258,000 |
| 9 | ResearchAndDevelopmentExpense | 118,499,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,419,000 |
| 13 | remainder_ComprehensiveNetIncome | -851,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 497,236,000 |
| 1 | Liabilities | 29,787,000 |
| 2 | Expenses | 151,757,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 467,449,000 |
| 5 | NetIncome | -149,338,000 |
| 6 | ComprehensiveNetIncome | -149,763,500 |
| 7 | BaseVar | 341,025,000 |
| 8 | EconomicCapitalRatio | 2.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
